Emerging Company Showcase
The European Neutotech Investing and Partnering conference will play host to an Emerging Company Showcase as part of the main conference program. This showcase allows neurotechnology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.
To be eligible to participate, companies must be:
- Addressing an unmet medical need
- Founded no earlier than 2012
- Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2016 are not eligible for this showcase)
To be considered, please submit your information via the form below no later than Wednesday, 6 September for consideration. Entries will be reviewed by the scientific advisory board and selected companies will be notified by 15 September. Selected companies will receive a discounted registration rate of €500.
* - required fields